DK2341344T3 - Fremgangsmåde til diagnosticering af en polycystisk nyresygdom - Google Patents

Fremgangsmåde til diagnosticering af en polycystisk nyresygdom

Info

Publication number
DK2341344T3
DK2341344T3 DK10196792.5T DK10196792T DK2341344T3 DK 2341344 T3 DK2341344 T3 DK 2341344T3 DK 10196792 T DK10196792 T DK 10196792T DK 2341344 T3 DK2341344 T3 DK 2341344T3
Authority
DK
Denmark
Prior art keywords
diagnosing
kidney disease
polycystic kidney
pkd
progression
Prior art date
Application number
DK10196792.5T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Universitätsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitätsklinikum Freiburg filed Critical Universitätsklinikum Freiburg
Application granted granted Critical
Publication of DK2341344T3 publication Critical patent/DK2341344T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Die Bonding (AREA)
  • Adhesive Tapes (AREA)
  • External Artificial Organs (AREA)
DK10196792.5T 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af en polycystisk nyresygdom DK2341344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (en) 2006-01-17 2006-01-17 Method for diagnosing polycystic kidney disease
EP07700227A EP1974210B1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
DK2341344T3 true DK2341344T3 (da) 2014-06-30

Family

ID=35945115

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10196792.5T DK2341344T3 (da) 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af en polycystisk nyresygdom
DK07700227.7T DK1974210T3 (da) 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af polycystisk nyresygdom

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07700227.7T DK1974210T3 (da) 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af polycystisk nyresygdom

Country Status (8)

Country Link
US (1) US20110229895A1 (da)
EP (3) EP1808694A1 (da)
AT (1) ATE493649T1 (da)
DE (1) DE602007011566D1 (da)
DK (2) DK2341344T3 (da)
ES (2) ES2475540T3 (da)
PL (2) PL2341344T3 (da)
WO (1) WO2007082733A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2637775A1 (en) * 2006-02-09 2007-08-16 Novartis Ag Antibodies against secreted frizzled related protein-4 (sfrp-4 )
ES2809171T3 (es) 2008-01-18 2021-03-03 Harvard College Métodos para detectar distintivos de enfermedades o afecciones en fluidos corporales
ES2526928T3 (es) 2008-04-30 2015-01-16 The Governing Council Of The University Of Toronto Uso de SFRP-3 en la evaluación de la insuficiencia cardíaca
WO2010079076A2 (de) * 2008-12-17 2010-07-15 Mosaiques Diagnostics And Therapeutics Ag Autosomal dominante polyzystische nierenerkrankung (adpkd)
EP3153863B1 (en) * 2009-11-07 2020-04-01 Astute Medical, Inc. Methods and uses for evaluation of acute renal failure/acute renal injury
AU2010336392B2 (en) * 2009-12-23 2014-01-23 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US20130266940A1 (en) 2010-07-23 2013-10-10 President And Fellows Of Harvard College Methods of Detecting Kidney-Associated Diseases or Conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CN103124795A (zh) 2010-07-23 2013-05-29 哈佛大学校长及研究员协会 利用吞噬细胞检测疾病或病症的方法
EP3062108B1 (en) * 2011-02-24 2019-06-19 Hill's Pet Nutrition, Inc. Methods for diagnosing kidney disorders in a feline
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
WO2014164366A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting cancer
WO2014197729A1 (en) * 2013-06-05 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2017001648A (es) 2014-08-04 2017-04-27 Genzyme Corp Biomarcadores de enfermedad poliquistica renal y usos de los mismos.
EP3693742B1 (en) 2014-09-11 2022-04-06 Harry Stylli Methods of detecting prostate cancer
WO2016149218A1 (en) * 2015-03-13 2016-09-22 Indiana University Research And Technology Corporation TARGETING cGMP-RELATED PHOSPHODIESTERASES TO REDUCE CYST FORMATION IN CYSTIC KIDNEY DISEASE, AND RELATED MATERIALS AND METHODS
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
CN108700594B (zh) 2015-11-18 2021-06-29 建新公司 多囊性肾病的生物标志物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (en) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation A novel human gene similar to a secreted murine protein sFRP-1
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
AU2001280680A1 (en) * 2000-07-19 2002-01-30 Genzyme Corporation Phosphatonin-related gene and methods of use thereof
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
US7879544B2 (en) * 2002-07-29 2011-02-01 Hmgene Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
WO2004076639A2 (en) * 2003-02-26 2004-09-10 Wyeth Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
MXPA06012446A (es) * 2004-04-29 2007-01-17 Genzyme Corp Metodos y composiciones para el tratamiento de enfermedades poliquisticas.

Also Published As

Publication number Publication date
ATE493649T1 (de) 2011-01-15
DE602007011566D1 (en) 2011-02-10
DK1974210T3 (da) 2011-02-21
EP2341344B1 (en) 2014-04-30
ES2356481T3 (es) 2011-04-08
EP1974210A1 (en) 2008-10-01
PL1974210T3 (pl) 2011-05-31
EP1974210B1 (en) 2010-12-29
EP2341344A1 (en) 2011-07-06
US20110229895A1 (en) 2011-09-22
WO2007082733A1 (en) 2007-07-26
ES2475540T3 (es) 2014-07-11
EP1808694A1 (en) 2007-07-18
PL2341344T3 (pl) 2014-09-30

Similar Documents

Publication Publication Date Title
DK2341344T3 (da) Fremgangsmåde til diagnosticering af en polycystisk nyresygdom
WO2008084331A3 (en) Biomarkers for renal disorders
DE602004026118D1 (de) Alkylxylolsulfonate für verbesserte ölrückgewinnungsverfahren
DK1831699T3 (da) Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme
BRPI0715126B8 (pt) métodos para avaliação do risco de intervenções cardíacas e usos à base de gdf-15
FR2894688B1 (fr) Procede de determination d'un jeu de lentilles ophtalmiques multifocales progressives.
EP2708899A3 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
FR2869698B1 (fr) Procede pour le controle et le diagnostic de machines
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
WO2008090319A3 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
DE602006015151D1 (de) Vorrichtung für Kompressionsanastomose
ATE473485T1 (de) Entdeckung von web-diensten
WO2007114901A3 (en) Method for diagnosing adhd and related behavioral disorders
ATE533859T1 (de) MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN
WO2007047408A3 (en) Promac signature application
BRPI0813422A2 (pt) Aparelho de poço, e, método para executar a intervenção, completação, teste ou perfuração de poço
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
DK1756571T3 (da) Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande
WO2007134028A3 (en) Biomarkers for depression and methods using the same
WO2006002240A8 (en) Computer systems and methods for constructing biological classifiers and uses thereof
ATE511657T1 (de) Bestimmungsverfahren für equine nt-probnp.
DE602008000683D1 (de) Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren
DE602006017336D1 (de) Prozessverbindung für prozessdiagnostik
WO2008102340A3 (en) Kits and methods for determining colon cleanliness